These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease? Papais Alvarenga RM, Araújo ACRAE, Nascimento ACB, Araujo NEC, Meneguette NS, Neri VC, Papais Alvarenga M, Filho HA, Barros PO, Bento CA, Schmidt SL, Vasconcelos CCF, Alvarenga MP. Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664 [Abstract] [Full Text] [Related]
27. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. Nakajima H, Motomura M, Tanaka K, Fujikawa A, Nakata R, Maeda Y, Shima T, Mukaino A, Yoshimura S, Miyazaki T, Shiraishi H, Kawakami A, Tsujino A. BMJ Open; 2015 Apr 02; 5(4):e007766. PubMed ID: 25838512 [Abstract] [Full Text] [Related]
28. Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications. Cobo-Calvo Á, Sepúlveda M, Bernard-Valnet R, Ruiz A, Brassat D, Martínez-Yélamos S, Saiz A, Marignier R. Mult Scler; 2016 Mar 02; 22(3):312-9. PubMed ID: 26209592 [Abstract] [Full Text] [Related]
29. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Rostásy K, Mader S, Hennes EM, Schanda K, Gredler V, Guenther A, Blaschek A, Korenke C, Pritsch M, Pohl D, Maier O, Kuchukhidze G, Brunner-Krainz M, Berger T, Reindl M. Mult Scler; 2013 Jul 02; 19(8):1052-9. PubMed ID: 23257621 [Abstract] [Full Text] [Related]
32. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein. Ducloyer JB, Michel L, Wiertlewski S, Lebranchu P. Eur J Ophthalmol; 2019 Mar 02; 29(2):257-261. PubMed ID: 29972029 [Abstract] [Full Text] [Related]
33. Simultaneous bilateral optic neuritis in China: clinical, serological and prognostic characteristics. Kang H, Liu Z, Li H, Chen T, Ai N, Xu Q, Cao S, Tao Y, Wei S. Acta Ophthalmol; 2019 May 02; 97(3):e426-e434. PubMed ID: 30632682 [Abstract] [Full Text] [Related]
34. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS). J Neuroinflammation; 2016 Sep 27; 13(1):280. PubMed ID: 27793206 [Abstract] [Full Text] [Related]
35. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease. Bianchi A, Cortese R, Prados F, Tur C, Kanber B, Yiannakas MC, Samson R, De Angelis F, Magnollay L, Jacob A, Brownlee W, Trip A, Nicholas R, Hacohen Y, Barkhof F, Ciccarelli O, Toosy AT. Mult Scler; 2024 May 27; 30(6):674-686. PubMed ID: 38646958 [Abstract] [Full Text] [Related]
36. Acute idiopathic optic neuritis: not always benign. Deschamps R, Gueguen A, Lecler A, Lecouturier K, Lamirel C, Bensa C, Marignier R, Vignal C, Gout O. Eur J Neurol; 2018 Nov 27; 25(11):1378-1383. PubMed ID: 30004610 [Abstract] [Full Text] [Related]
37. Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis. Caron-Cantin M, Cestari DM, Fortin E. Curr Opin Ophthalmol; 2019 Nov 27; 30(6):412-417. PubMed ID: 31503075 [Abstract] [Full Text] [Related]
38. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A. Neurology; 2012 Sep 18; 79(12):1273-7. PubMed ID: 22914827 [Abstract] [Full Text] [Related]
39. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M, in cooperation with the Neuromyelitis Optica Study Group (NEMOS). J Neuroinflammation; 2016 Sep 26; 13(1):279. PubMed ID: 27788675 [Abstract] [Full Text] [Related]
40. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Pröbstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, Lindberg RL, Kappos L, de Seze J, Derfuss T. J Neuroinflammation; 2015 Mar 08; 12():46. PubMed ID: 25889963 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]